News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
39,732 Results
Type
Article (2321)
Company Profile (7)
Press Release (37404)
Section
Business (10061)
Career Advice (16)
Deals (1228)
Drug Delivery (2)
Drug Development (8400)
Employer Resources (2)
FDA (731)
Job Trends (927)
News (19211)
Policy (1069)
Tag
Academia (207)
Accelerated approval (1)
Adcomms (5)
Allergies (6)
Alliances (3865)
ALS (41)
Alzheimer's disease (584)
Antibody-drug conjugate (ADC) (9)
Approvals (728)
Artificial intelligence (42)
Autoimmune disease (4)
Bankruptcy (13)
Best Places to Work (928)
Biotechnology (9)
Bladder cancer (6)
Brain cancer (3)
Breast cancer (61)
Cancer (466)
Cardiovascular disease (25)
Career advice (14)
Career pathing (2)
CAR-T (7)
Cell therapy (40)
Cervical cancer (6)
Clinical research (7032)
Collaboration (110)
COVID-19 (122)
CRISPR (7)
C-suite (7)
Cystic fibrosis (5)
Data (414)
Depression (5)
Diabetes (15)
Diagnostics (1436)
Digital health (1)
Drug discovery (17)
Drug pricing (2)
Duchenne muscular dystrophy (28)
Earnings (3749)
Editorial (3)
Employer resources (2)
Events (6467)
Executive appointments (48)
FDA (842)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (64)
Gene editing (12)
Generative AI (2)
Gene therapy (45)
GLP-1 (54)
Government (141)
Guidances (6)
Healthcare (1255)
Huntington's disease (8)
IgA nephropathy (2)
Immunology and inflammation (12)
Indications (6)
Infectious disease (127)
Inflammatory bowel disease (28)
Influenza (2)
Intellectual property (2)
Interviews (3)
IPO (623)
Job creations (57)
Job search strategy (13)
Kidney cancer (1)
Layoffs (11)
Legal (59)
Liver cancer (12)
Lung cancer (85)
Lymphoma (25)
Machine learning (2)
Management (1)
Manufacturing (2)
MASH (10)
Medical device (303)
Medtech (303)
Mergers & acquisitions (626)
Metabolic disorders (45)
Multiple sclerosis (13)
NASH (2)
Neurodegenerative disease (31)
Neuropsychiatric disorders (2)
Neuroscience (723)
NextGen: Class of 2025 (213)
Non-profit (231)
Now hiring (6)
Obesity (18)
Opinion (9)
Ovarian cancer (16)
Pain (4)
Pancreatic cancer (14)
Parkinson's disease (46)
Patents (12)
Patient recruitment (13)
Peanut (2)
People (2375)
Pharmaceutical (1)
Phase I (2675)
Phase II (3704)
Phase III (1642)
Pipeline (165)
Postmarket research (70)
Preclinical (689)
Press Release (3)
Prostate cancer (21)
Psychedelics (2)
Radiopharmaceuticals (16)
Rare diseases (41)
Real estate (168)
Recruiting (1)
Regulatory (1037)
Reports (4)
Research institute (240)
Resumes & cover letters (2)
Schizophrenia (10)
Series A (10)
Series B (6)
Sickle cell disease (6)
Special edition (2)
Spinal muscular atrophy (7)
Sponsored (1)
Startups (166)
Stomach cancer (6)
Supply chain (1)
Vaccines (23)
Venture capitalists (1)
Weight loss (6)
Women's health (2)
Date
Today (28)
Last 7 days (75)
Last 30 days (289)
Last 365 days (3530)
2025 (1221)
2024 (3616)
2023 (3844)
2022 (4252)
2021 (4318)
2020 (3408)
2019 (2641)
2018 (1797)
2017 (2036)
2016 (1750)
2015 (2001)
2014 (1305)
2013 (1092)
2012 (1078)
2011 (1193)
2010 (984)
Location
Africa (20)
Alabama (6)
Arizona (21)
Arkansas (1)
Asia (2024)
Australia (426)
California (712)
Canada (115)
China (33)
Colorado (36)
Connecticut (24)
Delaware (21)
Europe (6668)
Florida (74)
Georgia (5)
Illinois (38)
Indiana (25)
Japan (25)
Kansas (2)
Kentucky (1)
Maine (5)
Maryland (91)
Massachusetts (565)
Michigan (12)
Minnesota (11)
Missouri (15)
Montana (5)
Nebraska (2)
Nevada (12)
New Hampshire (2)
New Jersey (120)
New Mexico (10)
New York (196)
North Carolina (62)
Northern California (353)
Ohio (7)
Oklahoma (1)
Oregon (8)
Pennsylvania (100)
Rhode Island (2)
South America (17)
Southern California (264)
Tennessee (7)
Texas (90)
United States (2340)
Utah (54)
Virginia (21)
Washington D.C. (5)
Washington State (49)
Wisconsin (7)
39,732 Results for "banyan biomarkers".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioMark Diagnostics Underscores Commitment to Rare Disease Research on Rare Disease Day 2025
BioMark is pioneering liquid biopsy solutions for challenging conditions and championing equity in diagnosis
February 28, 2025
·
3 min read
Press Releases
LinusBio and The BRAIN Foundation Partner to Advance Biomarker-Supported Autism Diagnosis and Early Intervention
April 2, 2025
·
4 min read
Press Releases
IBL International collaborates with Grifols on advanced biomarker panels
April 9, 2025
·
3 min read
Press Releases
BioMark Announces the Final Closing of Oversubscribed Private Placement
March 31, 2025
·
8 min read
Press Releases
Neurovation Labs Expands IP Portfolio With Patent for Precision Brain Biomarker Detection Technology
April 22, 2025
·
2 min read
Press Releases
Fellow Health to Present Innovative Research on Prostate Cancer Biomarkers and PVSA Testing at AUA 2025
April 28, 2025
·
3 min read
Press Releases
Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine
April 10, 2025
·
6 min read
Cardiovascular disease
Lilly’s RNA Silencer Lowers Key Cardiovascular Biomarker by Almost 94%
BMO Capital Markets analysts said the results potentially position lepodisiran as “one of the most durable assets in development to date” in the competitive Lp(a) space, where drugs are designed to lower the risk of cardiovascular events such as heart attack and stroke.
March 31, 2025
·
2 min read
·
Tristan Manalac
Opinion
FDA Faces Challenging Decision on Biomarker-Based Label Restrictions
The FDA’s Oncologic Drugs Advisory Committee recently voted to narrow the label for checkpoint inhibitors Keytruda and Opdivo in stomach and esophageal cancers based on PD-L1 expression levels—but the high unmet need in these patient populations should also be considered.
March 10, 2025
·
5 min read
·
Harpreet Singh
Press Releases
BioMark Secures Financing for Initial Tranche to Advance Early-Detection Oncology Testing Platform
March 26, 2025
·
6 min read
1 of 3,974
Next
